Page last updated: 2024-12-07

aminoglutethimide phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aminoglutethimide phosphate is a medication used to treat Cushing's syndrome and some types of breast cancer. It works by blocking the production of cortisol, a hormone produced by the adrenal glands. Aminoglutethimide phosphate is typically taken orally. It can cause a number of side effects, including fatigue, dizziness, nausea, and vomiting. It is important to talk to your doctor about the risks and benefits of aminoglutethimide phosphate before taking it.'

aminoglutethimide phosphate: inhibitor of steroidogenesis; RN given refers to phosphate in unspecified proportion to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID86473
SCHEMBL ID11699322
MeSH IDM0086772

Synonyms (18)

Synonym
aminoglutethimide phosphate
glutarimide, 2-(p-aminophenyl)-2-ethyl-, phosphate (1:1)
aminoglutethimide phosphate, racemic
2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl-, phosphate (1:1)
alpha-(p-aminophenyl)-alpha-ethylglutarimide phosphate
2-(p-aminophenyl)-2-ethylglutarimide phosphate
elipten phosphate
23734-88-5
glutarimide, 2-(p-aminophenyl)-2-ethyl-, phosphate
13256-45-6
p-aminoglutethimide phosphate
2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl-, phosphate
SCHEMBL11699322
phosphoric acid--3-(4-aminophenyl)-3-ethyl-6-hydroxy-4,5-dihydropyridin-2(3h)-one (1/1)
DTXSID40927722
2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl-, phosphate (1:1) (8ci)
3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione;phosphoric acid
AKOS040732981

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (75.00)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]